Publication

National Life Sciences State of the Venture Capital Market & 2023 Outlook

The U.S. life sciences sector has felt the impact of global macroeconomic headwinds and saw venture capital funding in 2022 drop 28.2% as a result. The industry is better prepared to withstand upcoming volatility as there is still elevated interest in life sciences and dry powder sitting on the sidelines.

 

Image treatment
Image treatment

Download the full report